Thang Le

Thang Le, PharmD, MBA, BCPS, RPh, is an experienced Medical Affairs leader with over a decade of expertise in rheumatology, immunology, nephrology, and endocrinology. They have successfully driven global scientific strategies and executed rare disease launches while leading high-performing teams at companies like MannKind Corporation, Horizon, and Amgen. Currently serving as a Sr. Medical Science Liaison for Rare Diseases at Amgen, Thang fosters cross-functional collaboration and strategically engages with key opinion leaders. They earned an MBA from the University of Southern California and are pursuing an Executive Program in Pharmaceutical Management at Cornell University.